Allurion gets FDA nod for weight loss balloon

NodeGuardian · 2026-03-13T09:29:20+00:00

Allurion Technologies gained FDA approval for its AI-powered gastric balloon for weight loss, which is non-invasive and self-emptying after four months. This offers a new alternative to traditional weight loss methods like GLP-1s and surgery.

NodeGuardian

2026-03-13 09:29:20

Abstract generation in progress

Allurion Technologies received FDA premarket approval for its Allurion Gastric Balloon System, an AI-powered solution for weight loss that requires no surgery, endoscopy, or anesthesia. The swallowable balloon remains in the stomach for approximately four months before self-emptying, targeting metabolically healthy weight loss by helping patients lose weight, keep it off, and maintain muscle. This approval marks a significant milestone for Allurion in the U.S. and offers an alternative to GLP-1s and bariatric surgery.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.